CIDER Conference, medicine and research centerMay 21, 2013
CONFERENCE POSTPONED With respect to the delegation's visit to Madrid Cider, hospital officials have told Arab House, for various logistical difficulties, are forced to cancel your trip, so that the conference is postponed until further notice.
We regret any inconvenience this may cause.
Arab House organizes, on Tuesday May 21 in Madrid, a public lecture on the project CIDER by Dr. William F Owen Jr., executive director of Sidra Medical and Research Centre, Qatar Foundation. In his presentation, entitled "Medical and Research Center Sidra: vision, mission and goals, " Owen Jr. Spanish presented to the public objectives and projects of this high-level medical center dedicated to the care, training and research in the field of maternal and child health, who plans to become a reference center in the Middle East and Gulf.
The event, aimed at skilled health personnel in gynecology, obstetrics and pediatrics (medical / as, nurse / as, midwives, researchers) will be in English WITHOUT simultaneous translation. It will take place at the headquarters of Arab House in Madrid (c / Alcalá, 62) at 19:00 . Places exhausted. Those with confirmed space must be submitted in Arabic House at 18:30 for registration prior to the conference.
Any recruitment process for this hospital will be held directly by CIDER, and will be in English. All information about current vacancies can be found on their website (in English ).
Cider, reference center in MCH
The Medical and Research Center Cider (Sidra Medical and Research Center), Qatar Foundation for Education, Science and Community Development is an academic medical center and high-level MCH located in Doha.
It is endorsed by the Weill Cornell Medical College in Qatar (WCMC-Q), the Hamad Medical Corporation and Georgetown University. Located within the Education City, Sidra complex will initially have 400 beds, with possible extension to 550 at a later stage. In clinical terms, specialization is the gynecology, while research will focus on neonatal and pediatric medicine, as well as women's health, with a focus on diabetes, cancer and cardiovascular diseases.
Sidra plans to become a reference center in the Middle East and the Gulf in maternal and child health, covering three objectives: comprehensive patient care, biomedical research and medical education. To do this, the Qatar Foundation has given an important legacy, estimated at U.S. $ 7.9 billion, and has begun a process of selection of personnel and researchers through its website.
Dr. William F. Owen, Jr., MD, FACP
The Cricket Game
TV Series Episode Video on Demand ()
Phobia at the Gates2008-05-14 13:06:02 by china_blue
By Andrew Sullivan
Wednesday, May 14, 2008; Page A19
Twelve countries ban HIV-positive visitors, nonimmigrants and immigrants from their territory: Armenia, Brunei, Iraq, Libya, Moldova, Oman, Qatar, the Russian Federation, Saudi Arabia, South Korea, Sudan and . . . the United States. China recently acted to remove its ban on HIV-positive visitors because it feared embarrassment ahead of the Olympics. But America's ban remains.
It seems unthinkable that the country that has been the most generous in helping people with HIV should legally ban all non-Americans who are HIV-positive
You might also like:
$25m to move medical school — The Canberra Times
Plans are being drafted to refurbish the old heritage-listed John Curtin school of medical research, which was vacated in 2011, and to build a new $144 million state-of-the-art custom-built research centre next door.
Big Ten schools make strides in medical, agricultural research — Daily Nebraskan
Up north, the University of Minnesota-Twin Cities recently opened its new simulation center for the School of Nursing and the University of Wisconsin-Madison began a five-year research project on the dairy process.
Commercially-Available Drug to be Tested in Severe Form of Autism — Newswise
Newswise — Scientists at the Seaver Autism Center at the Icahn School of Medicine at Mount Sinai have received a grant from the National Institutes of Health (NIH) to study Insulin-Like Growth Factor-1 (IGF-1), a promising treatment for a subtype of ..